Federal regulator
Compounding and the FDA: questions and answers
Best for: the plain distinction between an approved finished drug and a medicine made by a compounder.
Read beside any claim that a compounded product has FDA approval.
Proof and records
A company logo, a listing in a government drug database and an FDA approval are three different things. Sellers sometimes show the first two as if they meant the third. Start with the claim, then open the public record that can actually answer it.
A reading list with notes, not a list of clinics.

Put claims beside records
Each question has its own office. FDA’s drug records show whether a medicine is approved. A state board shows whether a doctor or pharmacy is licensed. FDA’s compounding pages explain the rules for medicines a pharmacy mixes itself.
As of September 2026, FDA approval covers a particular drug product for a particular use; it does not attach to the broad word “peptide.”
As of September 2026, even a compounded medicine made by a licensed pharmacy lacks FDA approval.
An NDC number is a National Drug Code: a product code that can appear on a box or a seller’s page.
As of September 2026, an NDC number or an entry in a government drug directory does not mean FDA approved the product.
As of September 2026, a business being “FDA registered,” or a drug being listed with FDA, does not mean FDA approved it.
Which records to trust most
If the strongest record answers the question, stop there. More marketing does not make the answer stronger.
Annotated reading list
These links go to the government sites and professional groups this guide relied on.
Federal regulator
Best for: the plain distinction between an approved finished drug and a medicine made by a compounder.
Read beside any claim that a compounded product has FDA approval.
Federal regulator
Best for: the quality and review limits that apply before a compounded medicine reaches a patient.
Read before treating “made by a pharmacy” as the same as “approved.”
Federal regulator
Best for: current regulator concerns about compounded, fraudulent and research-labelled weight medicines.
Read when a claim compares a product without approval with an approved one.
Federal database
Best for: checking whether a medicine is really on FDA’s national shortage list today. During a national shortage, pharmacies are allowed to make their own copies of a brand-name medicine.
As of September 2026, what counts is FDA’s national shortage list, not one pharmacy being out of stock.
Licence links
Medical-board directory
Best for: reaching the official board that holds a doctor’s licence and public discipline record.
A clean record only tells you no public action shows up; it does not grade the quality of care.
Federal lookup page
Best for: jumping to the pharmacy licence search in the patient’s state.
Use the pharmacy name printed on the label, not only the name of the website arranging care.
Board association directory
Best for: reaching a state board directly when a pharmacy ships from somewhere else.
The state board’s own record is the final licence check.
Federal enforcement record
Best for: searching claims or practices that drew an FDA enforcement letter.
As of September 2026, a warning letter says FDA believes a company broke the rules at that time; it is not a court’s final ruling. Treat it as a reason to ask questions, not as proof.
Coverage links
Federal coverage program
Best for: who qualifies, which medicines are included, whether Medicare must approve the prescription before it pays, and the current end date.
Recheck the program page before relying on a price or deadline.
One last check
After checking the records, check the package, the contact route and urgent symptoms.